UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000028010
Receipt number R000032030
Scientific Title Randomized, double-blind, parallel group comparison trial of Tocilizumab for colchicine-resistant familial Mediterranean fever
Date of disclosure of the study information 2017/07/07
Last modified on 2021/12/16 11:11:47

No. Disposal Last modified on Item of update
1 Insert 2017/06/30 09:28:53
2 Update 2018/03/01 10:58:51
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
3 Update 2018/03/01 11:01:45 Research ethics review
4 Update 2018/03/01 11:03:27 Recruitment status
5 Update 2018/03/01 11:22:22 Date of protocol fixation
6 Update 2018/03/01 11:24:12 Organization1
Address1
Tel1
Email1
7 Update 2018/03/01 11:31:28 Key secondary outcomes
Key secondary outcomes
8 Update 2018/07/01 22:54:03 Institutions
9 Update 2018/09/03 13:45:40 Key exclusion criteria
Key exclusion criteria
10 Update 2019/02/06 23:26:57 Last follow-up date
11 Update 2019/05/11 09:15:10


12 Update 2019/06/08 20:38:24 Recruitment status
Date of IRB
13 Update 2019/07/02 09:20:06 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
14 Update 2020/01/07 18:40:39 Number of participants that the trial has enrolled
15 Update 2020/01/07 18:41:55 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
16 Update 2020/07/02 16:25:11 Recruitment status
17 Update 2021/12/16 11:11:47 Email